Thursday, June 11, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 80 of 1,261
  1. WO 2024243450

    MÉTHODES DE TRAITEMENT UTILISANT DES CONJUGUÉS ANTICORPS-MÉDICAMENT ANTI-C-MET

    ABBVIE INC [US] · Granted Nov 28, 2024 · Expires Nov 23, 2044

    granted
  2. WO 2024242579

    RÉGIMES DE TRAITEMENT DE LA MALADIE DE PARKINSON IDIOPATHIQUE PRÉCOCE

    BIAL PORTELA & CA SA [PT] · Granted Nov 28, 2024 · Expires Nov 23, 2044

    granted
  3. US 2024390317

    COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Nov 28, 2024 · Expires Nov 23, 2044

    granted
  4. US 2024390332

    Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Nov 28, 2024 · Expires Nov 23, 2044

    granted
  5. US 2024390367

    METHODS OF TREATING VITILIGO WITH UPADACITINIB

    ABBVIE INC [US] · Granted Nov 28, 2024 · Expires Nov 23, 2044

    granted
  6. US 12152270

    Neurotransmitter transport in probiotics

    Regents of the University of Minnesota · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  7. US 12152038

    Vasopressin receptor antagonists and products and methods related thereto

    Neumora Therapeutics, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  8. US 12152071

    EGFL6 specific monoclonal antibodies and methods of their use

    The Board of Regents of the University of Texas System · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  9. US 12150956

    Trace element compositions, methods of making and use

    American Regent, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  10. US 12152244

    Selective antisense compounds and uses thereof

    Ionis Pharmaceuticals, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  11. US 12152262

    PH20 polypeptide variants, formulations and uses thereof

    HALOZYME, INC. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  12. US 12150777

    Treatment of depression

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  13. US 12150461

    Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof

    Sovida Solutions Ltd. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  14. US 12151001

    Optimized expression cassettes for gene therapy

    Tenaya Therapeutics, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  15. US 12152028

    Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  16. US 12152242

    CRISPR therapy

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  17. US 12152034

    FGFR inhibitors and methods of making and using the same

    Relay Therapeutics, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  18. US 12151998

    Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  19. US 12151024

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  20. US 12152067

    Human antibodies to ebola virus glycoprotein

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  21. US 12152007

    Substituted heterocycles as c-MYC targeting agents

    Northwestern University · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  22. US 12151062

    Compositions and devices to administer pharmaceutical compositions nasally

    The Board of Regents of the University of Texas System · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  23. US 12152061

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  24. US 12150995

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.